We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aldagen Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke

News   Jan 05, 2011

 
Aldagen Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke
 
 
 

RELATED ARTICLES

Psoriasis Drug Target Holds Potential for Bone Cancer

News

Researchers have discovered a potential therapeutic target for osteosarcoma – one which is already used to treat psoriasis.

READ MORE

Evidence Reinforcing Approval of New Cancer Drugs Raises Questions

News

Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, according to a new study.

READ MORE

Discussing the Pros and Cons of CRISPR

News

CRISPR technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal Trends in Cell Biology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE